Skip to main content

Table 1 Genotype and allele frequencies of CDH1 promotor polymorphisms in patients with nephrolithasis and controls

From: Might E-cadherin promoter polymorphisms of rs16260 and rs5030625 associate with the risk of nephrolithiasis?

Genotypes and alleles

Patients

(n = 101)

n (%)

Controls

(n = 114)

n (%)

P values*

OR (95 % CI)*

P values**

HphI

(rs16260, −160 C > A)

  

0.124

  

 AA

10 (9.9)

22 (19.2)

 

1

 

 CA

39 (38.6)

35 (30.7)

 

2.80 (1.08–7.28)

0.033

 CC

52 (51.4)

57 (50.0)

 

2.16 (0.87–5.33)

0.094

 CA + CC

91 (90)

92 (80.7)

 

2.17 (0.97–4.85)

0.053

 Alleles

  

0.227

  

 A

59 (29.2)

79 (34.6)

 

1

 

 C

143 (70.7)

149 (65.3)

 

1.28 (0.85–1.93)

0.2281

BanII

(rs5030625, −347 G > GA)

  

0.523

  

 GA/GA

8 (7.92)

5 (4.38)

 

1

 

 G/GA

25 (24.7)

27 (23.6)

 

0.53 (0.14–2.05)

0.359

 G/G

68 (67.3)

82 (71.9)

 

0.45 (0.13–1.60)

0.220

 G/G + G/GA

93 (92)

109 (95.5)

 

0.53 (0.17–0.69)

0.278

 Alleles

  

0.333

  

 GA

41 (20.2)

37 (16.2)

 

1

 

 G

161 (79.7)

191 (83.7)

 

0.76 (0.46–1.24)

0.275

  1. Italics values means P value < 0.05
  2. OR odds ratio, 95 % CI 95 % confidence interval
  3. * χ 2 analysis between patients and controls
  4. ** P values were calculated AA vs. CA, CC and CA+CC; GA/GA vs. G/GA, G/G and G/G+G/GA by χ2 test